{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:51:48Z","timestamp":1762869108776,"version":"3.37.3"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":176,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.prdoa.2023.100208","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T07:28:17Z","timestamp":1687937297000},"page":"100208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Healthcare utilization, costs, and epidemiology of Huntington\u2019s disease in Israel"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3264-3380","authenticated-orcid":false,"given":"Yael","family":"Barer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinat","family":"Ribalov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4782-8203","authenticated-orcid":false,"given":"Ayelet","family":"Yaari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Maor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qais","family":"Arow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Logan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Chodick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2092-9848","authenticated-orcid":false,"given":"Tanya","family":"Gurevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.prdoa.2023.100208_b0005","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/mdc3.12808","article-title":"Movement Disorder Society Task Force viewpoint: Huntington's disease diagnostic categories","volume":"6","author":"Ross","year":"2019","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"4","key":"10.1016\/j.prdoa.2023.100208_b0010","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.prdoa.2023.100208_b0015","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40271-018-0312-x","article-title":"Understanding how chorea affects health-related quality of life in Huntington disease: an online survey of patients and caregivers in the United States","volume":"11","author":"Thorley","year":"2018","journal-title":"Patient"},{"issue":"1","key":"10.1016\/j.prdoa.2023.100208_b0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington's disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.prdoa.2023.100208_b0025","unstructured":"Xenazine\u00ae (tetrabenazine). Prescribing Information, Lundbeck, 2020."},{"key":"10.1016\/j.prdoa.2023.100208_b0030","unstructured":"Austedo\u00ae (deutetrabenazine) tablets. Prescribing Information, Teva Neuroscience, Inc. 2023."},{"issue":"2","key":"10.1016\/j.prdoa.2023.100208_b0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000443738","article-title":"The prevalence of Huntington's disease","volume":"46","author":"Rawlins","year":"2016","journal-title":"Neuroepidemiology"},{"issue":"10","key":"10.1016\/j.prdoa.2023.100208_b0040","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/ene.13107","article-title":"The societal cost of Huntington's disease: are we underestimating the burden?","volume":"23","author":"Jones","year":"2016","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.prdoa.2023.100208_b0045","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1186\/s12913-019-4806-6","article-title":"Economic burden of Huntington's disease in Peru","volume":"19","author":"Silva-Paredes","year":"2019","journal-title":"BMC Health Serv. Res."},{"issue":"1","key":"10.1016\/j.prdoa.2023.100208_b0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.36469\/9779","article-title":"Retrospective analysis of healthcare resource use, treatment patterns, and treatment-related events in patients with Huntington\u2019s disease-associated chorea initiated on tetrabenazine","volume":"6","author":"Sung","year":"2018","journal-title":"J. Health Econ. Outcomes Res."},{"issue":"8","key":"10.1016\/j.prdoa.2023.100208_b0055","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3111\/13696998.2013.818545","article-title":"The direct medical costs of Huntington's disease by stage. A retrospective commercial and Medicaid claims data analysis","volume":"16","author":"Divino","year":"2013","journal-title":"J. Med. Econ."},{"issue":"24","key":"10.1016\/j.prdoa.2023.100208_b0060","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2014.6634","article-title":"Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality","volume":"311","author":"Coresh","year":"2014","journal-title":"J. Am. Med. Assoc."},{"issue":"12","key":"10.1016\/j.prdoa.2023.100208_b0065","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1023\/B:EJEP.0000006635.36802.c8","article-title":"The epidemiology of diabetes in a large Israeli HMO","volume":"18","author":"Chodick","year":"2003","journal-title":"Eur. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.prdoa.2023.100208_b0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/HYPERTENSIONAHA.114.03718","article-title":"Prevalence and factors associated with resistant hypertension in a large health maintenance organization in Israel","volume":"64","author":"Weitzman","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.prdoa.2023.100208_b0075","unstructured":"Y. Fishler, A. Chetrit, M. Barchana, B. Modan, Estimation of completeness of the Cancer Registry in Israel, 2003."},{"key":"10.1016\/j.prdoa.2023.100208_b0080","unstructured":"Israel Central Bureau of Statistics, The 1995 Census of Population and Housing."},{"issue":"12","key":"10.1016\/j.prdoa.2023.100208_b0085","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1474-4422(14)70238-8","article-title":"Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study","volume":"13","author":"Paulsen","year":"2014","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.prdoa.2023.100208_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029522","article-title":"Characterization of a large group of individuals with huntington disease and their relatives enrolled in the COHORT study","volume":"7","author":"Dorsey","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.prdoa.2023.100208_b0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/jamaneurol.2015.2736","article-title":"Clinical-genetic associations in the Prospective Huntington at Risk Observational Study (PHAROS): implications for clinical trials","volume":"73","author":"Biglan","year":"2016","journal-title":"JAMA Neurol."},{"issue":"7","key":"10.1016\/j.prdoa.2023.100208_b0100","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.prdoa.2023.100208_b0105","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","article-title":"The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis","volume":"27","author":"Pringsheim","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2023.100208_b0110","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6","key":"10.1016\/j.prdoa.2023.100208_b0115","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1399-0004.2010.01603.x","article-title":"Huntington's disease in Greece: the experience of 14 years","volume":"80","author":"Panas","year":"2011","journal-title":"Clin. Genet."},{"issue":"3-S","key":"10.1016\/j.prdoa.2023.100208_b0120","first-page":"119","article-title":"Prevalence of Huntington disease in Italy: a systematic review and meta-analysis","volume":"91","author":"Ricco","year":"2020","journal-title":"Acta Biomed."},{"issue":"4","key":"10.1016\/j.prdoa.2023.100208_b0125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3233\/JHD-170286","article-title":"Tetrabenazine treatment patterns and outcomes for chorea associated with Huntington disease: a retrospective chart review","volume":"7","author":"Claassen","year":"2018","journal-title":"J. Huntingtons Dis."},{"issue":"5","key":"10.1016\/j.prdoa.2023.100208_b0130","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/mdc3.12506","article-title":"Hospitalizations of children with Huntington\u2019s Disease in the United States","volume":"4","author":"Mendizabal","year":"2017","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"2","key":"10.1016\/j.prdoa.2023.100208_b0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/JHD-120022","article-title":"Home or residential care? The role of behavioral and psychosocial factors in determining discharge outcomes for inpatients with Huntington's Disease","volume":"1","author":"Fisher","year":"2012","journal-title":"J. Huntingtons Dis."}],"container-title":["Clinical Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112523000269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112523000269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T11:15:20Z","timestamp":1736507720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590112523000269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":27,"alternative-id":["S2590112523000269"],"URL":"https:\/\/doi.org\/10.1016\/j.prdoa.2023.100208","relation":{},"ISSN":["2590-1125"],"issn-type":[{"type":"print","value":"2590-1125"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Healthcare utilization, costs, and epidemiology of Huntington\u2019s disease in Israel","name":"articletitle","label":"Article Title"},{"value":"Clinical Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prdoa.2023.100208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100208"}}